Loomis, Sayles & Company’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-119,436
Closed -$7.54M 1012
2022
Q2
$7.54M Sell
119,436
-7,016
-6% -$457K 0.01% 372
2022
Q1
$8.1M Sell
126,452
-5,777
-4% -$386K 0.01% 383
2021
Q4
$9.48M Buy
132,229
+48,584
+58% +$3.69M 0.01% 388
2021
Q3
$5.97M Sell
83,645
-327
-0.4% -$25.8K 0.01% 415
2021
Q2
$6.83M Buy
83,972
+27,635
+49% +$2.22M 0.01% 409
2021
Q1
$4.25M Sell
56,337
-66,934
-54% -$4.87M 0.01% 424
2020
Q4
$9.34M Sell
123,271
-6,800
-5% -$443K 0.01% 385
2020
Q3
$6.43M Buy
130,071
+27,113
+26% +$1.53M 0.01% 376
2020
Q2
$5.41M Buy
102,958
+15,141
+17% +$719K 0.01% 389
2020
Q1
$3.09M Sell
87,817
-81,015
-48% -$4.73M 0.01% 416
2019
Q4
$14.8M Sell
168,832
-5,311
-3% -$464K 0.03% 278
2019
Q3
$14.8M Sell
174,143
-536,667
-76% -$47.8M 0.03% 267
2019
Q2
$74.8M Buy
710,810
+28,742
+4% +$2.89M 0.14% 68
2019
Q1
$72M Sell
682,068
-10,541
-2% -$1.06M 0.14% 68
2018
Q4
$58M Sell
692,609
-86,894
-11% -$7.87M 0.14% 62
2018
Q3
$79.4M Sell
779,503
-35,580
-4% -$3.43M 0.16% 61
2018
Q2
$65.9M Buy
815,083
+67,008
+9% +$5.33M 0.13% 67
2018
Q1
$55.1M Sell
748,075
-88,473
-11% -$6.62M 0.12% 79
2017
Q4
$59M Buy
836,548
+57,151
+7% +$4.12M 0.12% 77
2017
Q3
$48.7M Buy
779,397
+215,039
+38% +$12.7M 0.11% 100
2017
Q2
$32.4M Buy
564,358
+358,612
+174% +$21.1M 0.08% 150
2017
Q1
$12.5M Buy
205,746
+55,353
+37% +$3.13M 0.03% 368
2016
Q4
$8.25M Sell
150,393
-27,713
-16% -$1.33M 0.02% 464
2016
Q3
$8.21M Sell
178,106
-39,162
-18% -$1.65M 0.02% 448
2016
Q2
$7.4M Buy
+217,268
New +$6.78M 0.02% 464

Other funds holding NGVT

Loomis, Sayles & Company's NGVT Position: Q3 2022 in Review

Loomis, Sayles & Company sold out of Ingevity (NGVT) in Q3 2022, closing a stake of 119,436 shares — an estimated $7.54M sold.

Loomis, Sayles & Company first reported a position in NGVT in Q2 2016 and held it in 25 quarters. The position peaked at $79.4M in Q3 2018. 269 funds tracked by Wall St. Rank hold NGVT as of Q3 2022.

  • Loomis, Sayles & Company reported no remaining Ingevity position as of Q3 2022 after selling out during the quarter.
  • Loomis, Sayles & Company sold 119,436 Ingevity shares in Q3 2022, an estimated $7.54M.
  • Loomis, Sayles & Company first reported a position in Ingevity in Q2 2016 and held it in 25 quarters.
  • Loomis, Sayles & Company's Ingevity position peaked at $79.4M in Q3 2018.
  • 269 funds tracked by Wall St. Rank held Ingevity as of Q3 2022.

Based on Loomis, Sayles & Company's 13F filing for Q3 2022, filed 14 Nov 2022.